{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:36:17Z","timestamp":1743068177036,"version":"3.38.0"},"reference-count":348,"publisher":"Akademiai Kiado Zrt.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Microbiologica et Immunologica Hungarica"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1556\/amicr.57.2010.4.2","type":"journal-article","created":{"date-parts":[[2010,12,24]],"date-time":"2010-12-24T02:03:49Z","timestamp":1293156229000},"page":"253-347","source":"Crossref","is-referenced-by-count":5,"title":["Antileukemia and antitumor effects of the graft-versus-host disease: A new immunovirological approach"],"prefix":"10.1556","volume":"57","author":[{"given":"Joseph","family":"Sinkovics","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"volume-title":"Graft-vs-Host Disease","year":"2005","author":"Ferrara J. L. M.","key":"1"},{"volume-title":"Wintrobe\u2019s Clinical Hematology","year":"2009","author":"Gadi V. K.","key":"2"},{"volume-title":"Hematology Basic Principles and Practice","year":"2005","author":"Reddy P.","key":"3"},{"key":"4","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1056\/NEJM197012102832421","article-title":"Lymphocytic cytotoxins in wasting syndrome","volume":"283","author":"Shullenberger C. C.","year":"1970","journal-title":"N. England. J. Med."},{"volume-title":"Genetic Concepts and Neoplasia","year":"1970","author":"Sinkovics J. G.","key":"5"},{"key":"6","first-page":"5","article-title":"Human natural killer cells: A comprehensive review","volume":"27","author":"Sinkovics J. G.","year":"2005","journal-title":"Int. J. Oncol."},{"key":"7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.24.1.1","article-title":"The effect of adult chicken organ grafts on the chick embryo","volume":"24","author":"Murphy J. B.","year":"1916","journal-title":"J. Exp. Med."},{"key":"8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1084\/jem.15.3.270","article-title":"The histological signs of resistance to a transmissible sarcoma of the fowl","volume":"15","author":"Rous P.","year":"1912","journal-title":"J. Exp. Med."},{"key":"9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1084\/jem.12.3.344","article-title":"An experimental comparison of transplanted tumor and a transplanted normal tissue capable of growth","volume":"12","author":"Rous P.","year":"1910","journal-title":"J. Exp. Med."},{"key":"10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1084\/jem.13.4.397","article-title":"A sarcoma of the fowl transmissible by an agent separable from the tumor cells","volume":"13","author":"Rous P.","year":"1911","journal-title":"J. Exp. Med."},{"key":"11","first-page":"103","article-title":"Immunological attack on newborn chickens by injected adult cells","volume":"2","author":"Cock A. G.","year":"1958","journal-title":"Immunology"},{"key":"12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/188376b0","article-title":"Graft versus host reactions on the chorioallantoic membrane of the chick embryo","volume":"188","author":"Burnet M.","year":"1960","journal-title":"Nature"},{"key":"13","first-page":"357","article-title":"Actively acquired tolerance","volume":"239","author":"Billingham R.","year":"1956","journal-title":"Phil. Trans. B"},{"key":"14","first-page":"21","article-title":"The biology of graft-versus-host reactions","volume":"62","author":"Billingham R. E.","year":"1966","journal-title":"Harvey Lec."},{"key":"15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-065X.1979.tb00282.x","article-title":"Complexity of the state of immunological tolerance","volume":"46","author":"Ha\u0161ek M.","year":"1979","journal-title":"Immunol. Rev."},{"key":"16","first-page":"255","article-title":"Induction of neonatal transplantation tolerance in mice: The role of H-2 complex and cell dose","volume":"24","author":"J\u00e1nossy T.","year":"1984","journal-title":"Ann. Immunol. Hung."},{"key":"17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2141.1957.tb05793.x","article-title":"Treatment of murine leukemia with x-rays and homologous bone marrow","volume":"3","author":"Barnes D.","year":"1957","journal-title":"Br. J. Haematol."},{"key":"18","first-page":"1525","article-title":"Adoptive immunotherapy of acute leukemia: Experimental and clinical results","volume":"25","author":"Math\u00e9 G.","year":"1965","journal-title":"Cancer Res."},{"key":"19","first-page":"421","article-title":"Transient graft-versus-host reaction in the treatment of leukemia in mice","volume":"41","author":"Borani\u0107 M.","year":"1968","journal-title":"J. Natl. Cancer Inst."},{"key":"20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.179.4075.811","article-title":"Graft versus leukemia: Quantification of adoptive immunotherapy in murine leukemia","volume":"179","author":"Bortin M. M.","year":"1973","journal-title":"Science"},{"key":"21","first-page":"162","article-title":"Apparent independent antihost and antileukemic activity of transplanted immunocompetent cells","volume":"16","author":"Bortin M. M.","year":"1973","journal-title":"Transplantation"},{"key":"22","first-page":"1851","article-title":"Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy and adoptive immunotherapy","volume":"34","author":"Bortin M. M.","year":"1974","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-1-4684-3300-5_27","article-title":"Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice","volume":"73PtB","author":"Bortin M. M.","year":"1976","journal-title":"Adv. Exp. Med. Biol."},{"key":"24","first-page":"1658","article-title":"Graft versus leukemia for \u201ccell cure\u201d of long-passage AKR leukemia after chemoradiotherapy","volume":"32","author":"Salzstein E. C.","year":"1971","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/BF01939025","article-title":"Prolonged survival of AKR mice following allogeneic bone marrow transplantation","volume":"30","author":"Rose W. C.","year":"1974","journal-title":"Experientia"},{"key":"26","first-page":"569","article-title":"Graft-versus-leukemia for AKRspontaneous leukemia-lymphoma","volume":"8","author":"Truitt R. L.","year":"1976","journal-title":"Transplant. Proc."},{"key":"27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ijc.2910210215","article-title":"Adoptive immunochemotherapy of a transplantable AKR leukemia (K36)","volume":"21","author":"Putman D. L.","year":"1978","journal-title":"Int. J. Cancer"},{"key":"28","first-page":"331","article-title":"Traitement de souris AkR \u00e0 l\u2019\u00e2ge de six mois par irradiation totale suivie de transfusion de cellules h\u00e9matopo\u00ef\u00e9tiques allog\u00e9niques. Incidences respectives de la leuc\u00e9mie et du syndrome secondaire","volume":"47","author":"Math\u00e9 G.","year":"1960","journal-title":"Bull. Cancer"},{"key":"29","first-page":"416","article-title":"Essai de traitement de la leuc\u00e9mie de Charlotte Friend par la greffe de cellules h\u00e9matopo\u00ef\u00e9tiques de donneurs isog\u00e9niques vaccin\u00e9es contre le virus","volume":"49","author":"Math\u00e9 G.","year":"1962","journal-title":"Bull. Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1083-8791(03)00087-9","article-title":"Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus leukemia responses","volume":"9","author":"Korngold R.","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01258761","article-title":"Observations on various runting syndromes in mice","volume":"12","author":"Sinkovics J.","year":"1962","journal-title":"Arch. Ges. Virusforsch."},{"key":"32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/infdis\/110.3.282","article-title":"Abnormal immune and other complicating phenomena associated with a viral mouse leukemia","volume":"110","author":"Sinkovics J. G.","year":"1962","journal-title":"J. Inf. Dis."},{"volume-title":"Conceptual Advances in Immunology and Oncology","year":"1963","author":"Sinkovics J. G.","key":"33"},{"key":"34","first-page":"591","article-title":"Approaches to the pathogenesis of runt (homologous) disease","volume":"22","author":"Sinkovics J. G.","year":"1964","journal-title":"Texas Rep. Biol. Med."},{"key":"35","first-page":"62","article-title":"Effect of hematopoietic chimerism on the course of Rauscher viral mouse leukemia","volume":"4\/1","author":"Sinkovics J. G.","year":"1963","journal-title":"Proc. Am. Assoc. Cancer Res. 54th Ann. Meeting, Toronto, Canada"},{"key":"36","first-page":"59","article-title":"Interferon production, antibody response and homograft rejection-type defense mechanism in viral mouse leukemia","volume":"5\/1","author":"Sinkovics J. G.","year":"1964","journal-title":"Proc. Am. Assoc. Cancer Res. 55th Ann. Meeting, Chicago, IL"},{"key":"37","first-page":"1:36","article-title":"Prolongation and prevention of Rauscher virus mouse leukemia by spleen cells of naturally resistant or actively immunized mice","volume":"13","author":"Sinkovics J. G.","year":"1965","journal-title":"Offic. Publ. Am. Fed. Clin. Res. Natl. Meeting Atlantic City, NJ"},{"key":"38","first-page":"65","article-title":"Treatment of leukemic mice with irradiation and adoptive immunization","volume":"7","author":"Sinkovics J. G.","year":"1966","journal-title":"Proc. Am. Assoc. Cancer Res. 57th Ann. Meeting, Denver; Colorado"},{"key":"39","first-page":"94","article-title":"Immunological functions of homologous spleen cells in viral mouse leukemia","volume":"23","author":"Sinkovics J. G.","year":"1965","journal-title":"Texas Rep. Biol. Med."},{"key":"40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01241994","article-title":"Mouse leukemia, a dichotomy of virus neutralizing and cytotoxic antibodies","volume":"19","author":"Sinkovics J. G.","year":"1966","journal-title":"Arch. Ges. Virusforsch."},{"volume-title":"Carcinogenesis: A Broad Critique","year":"1967","author":"Sinkovics J. G.","key":"41"},{"key":"42","first-page":"624","article-title":"Some properties of the photodynamically inactivated Rauscher mouse leukemia virus","volume":"25","author":"Sinkovics J. G.","year":"1965","journal-title":"Cancer Res."},{"volume-title":"The Immunology of Malignant Disease","year":"1976","author":"Sinkovics J. G.","key":"43"},{"key":"44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1749-6632.1976.tb41682.x","article-title":"Discussion paper: Modalities of immunotherapy for virally induced murine neoplasms","volume":"276","author":"Sinkovics J. G.","year":"1976","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"45","first-page":"88","article-title":"Neutralization of sublines of a mouse leukemia virus with murine antibody as measured by the spleen focus assay","volume":"27","author":"Sinkovics J. G.","year":"1967","journal-title":"Cancer Res."},{"key":"46","first-page":"474","article-title":"Viral leukemogenesis in immunologically and hematologically altered mice","volume":"8","author":"Sinkovics J. G.","year":"1970","journal-title":"J. Reticuloendothel. Soc."},{"volume-title":"Autologous Marrow and Blood Transplantion, 1994","year":"1995","author":"Sinkovics J. G.","key":"47"},{"volume-title":"The Proliferation and Spread of Neoplastic Cells","year":"1968","author":"Sinkovics J. G.","key":"48"},{"key":"49","first-page":"73","article-title":"Effects of hematopoietic and immunological alterations in newborn mice on leukemogenesis and tumor growth","volume":"11","author":"Sinkovics J. G.","year":"1970","journal-title":"Proc. Am. Assoc. Cancer Res. 61st Ann. Meeting, Philadelphia, PA"},{"key":"50","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1126\/science.158.3804.1061","article-title":"Murine lymphoma: Augmented growth in mice with pertussis vaccine-induced lymphocytosis","volume":"158","author":"Hirano M.","year":"1967","journal-title":"Science"},{"key":"51","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/BF02138660","article-title":"Actions of interferon in tissue cultures harboring mouse leukemia virus","volume":"4","author":"Sinkovics J. G.","year":"1968","journal-title":"Experientia"},{"volume-title":"Cancer in Africa","year":"1968","author":"Sinkovics J. G.","key":"52"},{"volume-title":"Immunity and Tolerance in Oncogenesis","year":"1969","author":"Sinkovics J. G.","key":"53"},{"key":"54","doi-asserted-by":"crossref","DOI":"10.1556\/AMicr.55.2008.4.2","volume-title":"Cytolytic Immune Lymphocytes in the Armamentarium of the Human Host","author":"Sinkovics J. G.","year":"2008"},{"key":"55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1556\/AMicr.55.2008.4.2","article-title":"Cytolytic immune lymphocytes in the armamentarium of the human host","volume":"5","author":"Sinkovics J. G.","year":"2008","journal-title":"Acta Microbiol. Immunol. Hung."},{"volume-title":"The Immunology of Malignant Disease","year":"1976","author":"Sinkovics J. G.","key":"56"},{"key":"57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/bbmt.2003.50027","article-title":"Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response","volume":"9","author":"Jones S. C.","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbmt.2003.10.002","article-title":"Specific donor V\u03b2-associated responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens","volume":"10","author":"Jones S. C.","year":"2004","journal-title":"Biol. Blood Marrow Transplant."},{"key":"59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00199697","article-title":"The role of humoral immunity and the contribution of the F1 anti-parental effect in the rejection of a Moloney leukemia virus-induced lymphoma graft","volume":"15","author":"Asj\u00f6 A.","year":"1983","journal-title":"Cancer Immunol. Immmunother."},{"key":"60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF01561677","article-title":"Reduced humoral and cellular cytotoxic sensitivity in histocompatibility variants of the YAC (Moloney) lymphoma","volume":"12","author":"Dalianis T.","year":"1981","journal-title":"Immunogenetics"},{"key":"61","first-page":"947","article-title":"Cytotoxic and neutralization tests with serum and lymph node cells of isologous mice with induced resistance against Gross lymphomas","volume":"22","author":"Slettenmark B.","year":"1962","journal-title":"Cancer Res"},{"key":"62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.105.4.307","article-title":"Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia","volume":"105","author":"Friend C.","year":"1957","journal-title":"J. Exp. Med."},{"key":"63","first-page":"120","article-title":"Immunological relationship of a filterable agent causing leukemia in adult mice. I. The neutralization of infectivity by specific antiserum","volume":"119","author":"Friend C.","year":"1959","journal-title":"J. Exp. Med."},{"key":"64","first-page":"111","article-title":"Cytotoxic assays and other immunologic studies induced by Friend virus","volume":"31","author":"Wahren B.","year":"1963","journal-title":"J. Natl. Cancer Inst."},{"key":"65","first-page":"1063","article-title":"Formation of cytotoxic antibody against leukemias induced by Friend virus","volume":"23","author":"Old L.","year":"1963","journal-title":"Cancer Res."},{"key":"66","first-page":"1075","article-title":"Immune reactions to a murine leukemia virus. Induction of immunity to infection with virus in the natural host","volume":"32","author":"Fink M. A.","year":"1964","journal-title":"J. Natl. Cancer Inst."},{"key":"67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-8794-3-2","article-title":"Gene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirus","volume":"3","author":"Voisin V.","year":"2010","journal-title":"BMC Med. Genomics"},{"key":"68","first-page":"661","article-title":"The immunosuppressive effect of the Graffi leukemia virus","volume":"16","author":"Ancheva M.","year":"1971","journal-title":"Vopr. Virusol."},{"key":"69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(08)60328-0","article-title":"Antigens induced by the mouse leukemia viruses","volume":"12","author":"Pasternak G.","year":"1969","journal-title":"Adv. Cancer Res."},{"key":"70","first-page":"65","article-title":"Immunological studies on virus and cell interaction with a mouse leukemia virus","volume":"15","author":"Pasternak G.","year":"1968","journal-title":"Zentralbl. Veterin\u00e4rmed. B"},{"key":"71","first-page":"618","article-title":"Activities of immune lymphoid cells against leukemia virus-carrier murine neoplastic cells","volume":"36","author":"Sinkovics J. G.","year":"1970","journal-title":"Bibl. Haematol."},{"key":"72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01241277","article-title":"Influence and production of interferon in Rauscher virus infected mice","volume":"20","author":"Vandeputte M.","year":"1967","journal-title":"Arch. Ges. Virusforsch."},{"key":"73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/JVI.3.2.99-105.1969","article-title":"Interferon and host resistance to Rauscher virus-induced leukemia","volume":"3","author":"Glasgow L. A.","year":"1969","journal-title":"J. Virol."},{"key":"74","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ijc.2910350415","article-title":"The effect of murine interferon-alpha\/beta on an established Rauscher murine leukemia virus-induced erythroleukemia in BALB\/c mice","volume":"35","author":"Hekman R. A.","year":"1985","journal-title":"Int. J. Cancer"},{"key":"75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/jnci\/80.2.126","article-title":"Effectiveness of mouse interferon alpha\/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculation of Friend erythroleukemia cells","volume":"80","author":"Gresser I.","year":"1988","journal-title":"J. Natl. Cancer Inst."},{"key":"76","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/eji.200838311","article-title":"Anti-retroviral effects of type I IFN subtypes in vivo","volume":"39","author":"Gerlach N.","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"77","first-page":"631","article-title":"Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon","volume":"36","author":"Bekesi J. G.","year":"1976","journal-title":"Cancer Res."},{"key":"78","first-page":"993","article-title":"Inhibitory effect of interferon on multiplication of Friend leukemia cells in vivo","volume":"54","author":"Rossi G. B.","year":"1975","journal-title":"J. Natl. Cancer Inst."},{"key":"79","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ijc.2910310518","article-title":"Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously","volume":"31","author":"Belardelli F.","year":"1983","journal-title":"Int. J. Cancer"},{"key":"80","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ijc.2910570427","article-title":"Interaction of IFN alpha\/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice","volume":"57","author":"Gresser I.","year":"1994","journal-title":"Int. J. Cancer"},{"key":"81","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ijc.2910630520","article-title":"The essential role of endogenous IFN alpha\/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells","volume":"63","author":"Gresser I.","year":"1995","journal-title":"Int. J. Cancer"},{"key":"82","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.2910460324","article-title":"Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VII. Role of the immune system in the inhibition of visceral metastases","volume":"46","author":"Gresser I.","year":"1990","journal-title":"Int. J. Cancer"},{"key":"83","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/jir.2007.9972","article-title":"My tortuous journey to a life in interferon research","volume":"27","author":"Chany C.","year":"2007","journal-title":"J. Interferon Cytokine Res."},{"key":"84","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/jir.2007.9986","article-title":"Interferons an unfolding tale","volume":"27","author":"Gresser I.","year":"2007","journal-title":"J. Interferon Cytokine Res."},{"key":"85","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/223845a0","article-title":"Inhibitory effect of interferon on murine sarcoma and leukaemia virus infection in vitro","volume":"223","author":"Sarma P. S.","year":"1969","journal-title":"Nature"},{"key":"86","first-page":"455","article-title":"Decrease of sensitivity to interferon in cells infected by murine leukemia-sarcoma viruses","volume":"51","author":"P\u00e9ri\u00e9s J.","year":"1973","journal-title":"J. Natl. Cancer Inst."},{"key":"87","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1099\/0022-1317-34-2-305","article-title":"Mechanism of polykaryocyte induction by vesicular stomatitis virus in rat XC cells","volume":"34","author":"Chany-Fournier F.","year":"1977","journal-title":"J. Gen. Virol."},{"key":"88","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1007\/s00005-008-0047-9","article-title":"Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers","volume":"56","author":"Sinkovics J. G.","year":"2008","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"89","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.4049\/jimmunol.181.5.3432","article-title":"Lymphocyte activation by coinfection prevents immune control of Friend virus infection","volume":"181","author":"Marques R.","year":"2008","journal-title":"J. Immunol."},{"key":"90","first-page":"771","article-title":"Inhibitory effects of Sendai virus on Friend virus leukemia in mice","volume":"38","author":"Wheelock E. F.","year":"1967","journal-title":"J. Natl. Cancer Inst."},{"key":"91","doi-asserted-by":"crossref","first-page":"11211","DOI":"10.1128\/JVI.01225-09","article-title":"Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection","volume":"83","author":"Pike R.","year":"2009","journal-title":"J. Virol."},{"key":"92","first-page":"449","article-title":"Mechanisms of the stimulating action of the Rauscher leukemia virus on togavirus reproduction in the bodies of BALB\/c strain mice","volume":"4","author":"Pogodina V. V.","year":"1980","journal-title":"Vopr. Virusol."},{"key":"93","first-page":"61","article-title":"Study on the mechanism of interference between Friend leukemia and Sindbis viruses in tissue culture","volume":"23","author":"Pogodina V. V.","year":"1976","journal-title":"Neoplasma"},{"key":"94","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1063005","article-title":"Regulation of the immune response by antigen","volume":"293","author":"Zinkernagel R. M.","year":"2001","journal-title":"Science"},{"key":"95","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2008.09.016","article-title":"Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology","volume":"29","author":"Antunes I.","year":"2008","journal-title":"Immunity"},{"key":"96","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/IAI.11.1.129-136.1975","article-title":"Suppression of established Friend virus leukemia by statolon: Potentiation of statolon\u2019s leukemosuppressive activity by chlorite-oxidized oxyamylose","volume":"1","author":"Weislow O. S.","year":"1975","journal-title":"Infect. Immun."},{"key":"97","first-page":"23","article-title":"Interferon and antibody production in inbred mice infected with the Rauscher virus","volume":"18","author":"T\u00f3th F. D.","year":"1971","journal-title":"Acta Micriobiol. Acad. Sci. Hung."},{"key":"98","first-page":"109","article-title":"Effect of interferon treatment on the tumour-specific antibody response of BALB-c mice infected with Rauscher virus","volume":"18","author":"T\u00f3th F. D.","year":"1971","journal-title":"Acta Microbiol. Acad. Sci. Hung."},{"key":"99","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/IAI.21.3.925-930.1978","article-title":"Interferon treatment of NZB mice: Accelerated progression of autoimmune disease","volume":"21","author":"Heremans H.","year":"1978","journal-title":"Infect. Immun."},{"key":"100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000209125","article-title":"The Rauscher virus: A mixture of the Friend virus and the mouse leukemia virus (Gross)?","volume":"35","author":"Gross L.","year":"1966","journal-title":"Acta Haematol."},{"key":"101","first-page":"18","article-title":"The earliest concept of the \u201chybridoma principle\u201d recognized in 1967\u20131968","volume":"24","author":"Sinkovics J. G.","year":"1990","journal-title":"Front Rad. Ther. Oncol."},{"key":"102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/AMicr.52.2005.1.1","article-title":"A notable phenomenon recapitulated. Fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously","volume":"52","author":"Sinkovics J. G.","year":"2005","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"103","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2826.x","article-title":"Transcription factor Fli-1 expression by bone marrow cells in chronic myeloproliferative disorders is independent of an underlying JAK2 (V617F) mutation","volume":"77","author":"Bock O.","year":"2006","journal-title":"Eur. J. Haematol."},{"key":"104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/14737140.7.1.31","article-title":"Adult human sarcomas. I. Basic science","volume":"7","author":"Sinkovics J. G.","year":"2007","journal-title":"Exp. Rev. Anticancer Ther."},{"key":"105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/14737140.7.2.183","article-title":"Adult human sarcomas. II. Medical oncology","volume":"7","author":"Sinkovics J. G.","year":"2007","journal-title":"Exp. Rev. Anticancer Ther."},{"key":"106","first-page":"83","article-title":"Friend leukemia virus integration-1 (FLI-1) expression in gastrointestinal stromal tumors","volume":"20","author":"Kaygusuz G.","year":"2009","journal-title":"Turk. J. Gastroenterol."},{"key":"107","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1099\/0022-1317-82-6-1349","article-title":"The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus)","volume":"82","author":"Strestik B. D.","year":"2001","journal-title":"J. Gen. Virol."},{"key":"108","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1084\/jem.145.3.594","article-title":"Spontaneous regression of Friend virus-induced erythroleukemia. I. The role of the helper mouse leukemia virus component","volume":"145","author":"Dietz M.","year":"1977","journal-title":"J. Exp. Med."},{"key":"109","first-page":"202","article-title":"The regulation of differentiation in murine virus-induced erythroleukemia cells","volume":"11","author":"Friend C.","year":"1980","journal-title":"Cell Differ"},{"key":"110","first-page":"48","article-title":"Antitumor activity of L-asparaginase and rifampicin","volume":"2","author":"Sinkovics J. G.","year":"1941","journal-title":"Lancet"},{"key":"111","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ijc.2910140616","article-title":"Inhibition by streptovaricins of Rauscher virus splenomegaly","volume":"14","author":"Borden E. C.","year":"1974","journal-title":"Int. J. Cancer"},{"key":"112","first-page":"161","article-title":"Inhibition of erythroid differentiation of mouse erythroleukemia cells by a macrophage product(s)","volume":"13","author":"Sassa S.","year":"1987","journal-title":"Blood Cells"},{"key":"113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0042-6822(88)90068-2","article-title":"Opposite effects of murine interferons on erythroid differentiation of Friend cells","volume":"5","author":"Affabris E.","year":"1988","journal-title":"Virology"},{"key":"114","first-page":"2880","article-title":"Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action","volume":"52","author":"Sala A.","year":"1992","journal-title":"Cancer Res"},{"key":"115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/JVI.75.2.654-660.2001","article-title":"Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection","volume":"75","author":"Dittmer U.","year":"2001","journal-title":"J. Virol."},{"key":"116","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1099\/vir.0.015834-0","article-title":"Mechanisms of control of acute Friend virus infection by CD4+ helper T cells and their functional impairment by regulatory T cells","volume":"91","author":"Nair S. R.","year":"2009","journal-title":"J. Gen. Virol."},{"key":"117","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1182\/blood-2005-11-026823","article-title":"Enhanced natural killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia","volume":"109","author":"Cervi D.","year":"2007","journal-title":"Blood"},{"key":"118","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1128\/JVI.75.7.3152-3163.2001","article-title":"Role of natural killer cells in resistance against Friend retrovirus-induced leukemia","volume":"75","author":"Iwanami N.","year":"2001","journal-title":"J. Virol."},{"key":"119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ijc.2910200113","article-title":"Separation of the Moloney leukemia virus-determined cell surface antigen (MCSA) from known virion proteins associated with the cell membrane","volume":"20","author":"Siegert W.","year":"1977","journal-title":"Int. J. Cancer"},{"key":"120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ijc.2910250510","article-title":"Killing of normal cells by activated mouse natural killer cells: Evidence for two patterns of genetic regulation of lysis","volume":"25","author":"Kiessling R. W.","year":"1980","journal-title":"Int. J. Cancer"},{"key":"121","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/eji.1830130910","article-title":"Natural cytotoxicity in the mouse embryo: Characterization of yolk sac-associated natural cytotoxic cells and their activity","volume":"13","author":"Dahl C. A.","year":"1983","journal-title":"Eur. J. Immunol."},{"key":"122","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-3083.1997.d01-156.x","article-title":"Selective cytotoxicity of two rodent T cell lymphomas to rat yolk sac tumours involves a retroviral envelope protein expressed by the lymphoma","volume":"46","author":"Lindvall M.","year":"1997","journal-title":"Scand. J. Immunol."},{"key":"123","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.exphem.2008.07.002","article-title":"Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation","volume":"36","author":"Prigozhina T. B.","year":"2008","journal-title":"Exp. Hematol."},{"key":"124","first-page":"1013","article-title":"Application of low dose of fludarabine and cyclophosphamide combined with donor NK cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice","volume":"15","author":"Yu P.","year":"2007","journal-title":"Zhongguo Shi Yan XueYe Xue Za Zhi"},{"key":"125","first-page":"107","article-title":"The action of donor-derived NK cell in leukemic mice MHC haplotype-mismatched bone marrow transplantation","volume":"30","author":"Wang C. Y.","year":"2009","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"126","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood-2008-09-181677","article-title":"Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras","volume":"113","author":"Ghosh A.","year":"2009","journal-title":"Blood"},{"key":"127","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1002\/eji.200737408","article-title":"Donor double-negative Treg promote allogeneic mixed chimerism and tolerance","volume":"37","author":"He K. M.","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"128","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4049\/jimmunol.181.2.1034","article-title":"Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade","volume":"181","author":"Verbinnen B.","year":"2008","journal-title":"J. Immunol."},{"key":"129","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/sj.leu.2404720","article-title":"CTLA4-blockade in murine bone marrow chimeras induces a host-derived anti-leukemia effect without graft-versus-host disease","volume":"21","author":"Fevery S.","year":"2007","journal-title":"Leukemia"},{"key":"130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1083-8791(03)00288-X","article-title":"An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression","volume":"9","author":"Whitaker-Menezes D.","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/sj.jid.5700583","article-title":"Cytokeratin 15-positive basal epithelial cells targeted in graft-versus-host disease express a constitutive anti-apoptotic phenotype","volume":"127","author":"Zhan Q.","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"132","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00043426-199302000-00003","article-title":"Biology of graft-vs.-host disease","volume":"15","author":"Korngold R.","year":"1993","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"key":"133","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/bbmt.2001.v7.pm11349805","article-title":"Infusion of select leukemia-reactive TCR Vbeta+ T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation","volume":"7","author":"Patterson A. E.","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2004.10.002","article-title":"Cytokines and cytotoxic pathways in engraftment resistance to purified hematopoietic stem cells","volume":"11","author":"Scheffold C.","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"volume-title":"Cytolytic Lymphocytes and Complement: Effectors of the Immune System. Volume II","year":"1988","author":"Podack E. R.","key":"135"},{"key":"136","first-page":"295","article-title":"Malignant lymphoma arising from natural killer cells: Report of the first case in 1970 and newer developments of the FasL \u2192 FasR system","volume":"44","author":"Sinkovics J. G.","year":"1997","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"137","first-page":"473","article-title":"Virological and immunological connotations of apoptotic and anti-apoptotic forces in neoplasia","volume":"19","author":"Sinkovics J. G.","year":"2001","journal-title":"Int. J. Oncology"},{"volume-title":"Cytotoxic Lymphocytes: Basic Mechanisms and Medical Applications","year":"2000","author":"Sitkovsky M. V.","key":"138"},{"key":"139","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.4049\/jimmunol.0902614","article-title":"The CCL3\/macrophage inflammatory protein-1 (alpha)-binding protein evasin-1 protects from graft-versus-host disease but not modify graft-versus leukemia in mice","volume":"184","author":"Castor M. G.","year":"2010","journal-title":"J. Immunol."},{"key":"140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbmt.2009.12.002","article-title":"Chemokine receptor CCR5 mediates allo-immune responses in graft-vs-host diaease","volume":"16","author":"Palmer L. A.","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"141","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki A.","year":"2004","journal-title":"Nat. Immunol."},{"key":"142","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2307\/3573066","article-title":"Mortality and gross pathology of secondary disease in germ-free mouse radiation chimeras","volume":"45","author":"Jones J. M.","year":"1971","journal-title":"Radiat. Res."},{"volume-title":"Williams Hematology","year":"2006","author":"Berger C.","key":"143"},{"key":"144","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1182\/blood-2009-12-258756","article-title":"Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development","volume":"115","author":"B\u00f6iers C.","year":"2010","journal-title":"Blood"},{"key":"145","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.4049\/jimmunol.0900685","article-title":"In vivo role of Flt3 ligand and dendritic cells in NK homeostasis","volume":"184","author":"Guimond M.","year":"2010","journal-title":"J. Immunol."},{"key":"146","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.it.2006.03.004","article-title":"A unified theory of central tolerance in the thymus","volume":"27","author":"Liu Y. J.","year":"2006","journal-title":"Trends Immunol."},{"key":"147","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nature03886","article-title":"Hassall\u2019s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus","volume":"436","author":"Watanabe N.","year":"2005","journal-title":"Nature"},{"key":"148","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2005.07.005","article-title":"Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation","volume":"117","author":"Miller J. S.","year":"2005","journal-title":"Clin. Immunol."},{"key":"149","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/bmt.2009.357","article-title":"The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT","volume":"45","author":"Bao X. J.","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.seminhematol.2005.01.010","article-title":"Natural killer cell receptors: Regulating innate immune responses to hematologic malignancy","volume":"42","author":"Hsu K. C.","year":"2005","journal-title":"Semin. Hematol."},{"key":"151","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.seminhematol.2005.01.007","article-title":"Complex interactions: The immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors","volume":"42","author":"Norman P. J.","year":"2005","journal-title":"Semin. Hematol."},{"key":"152","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1182\/blood-2009-08-236943","article-title":"Donor activating KIR3DS1 is associated with decreased acute GvHD in unrelated allogeneic stem cell transplantation","volume":"115","author":"Venstrom J. M.","year":"2010","journal-title":"Blood"},{"key":"153","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger?","volume":"327","author":"Schroder K.","year":"2010","journal-title":"Science"},{"key":"154","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/emmm.200900014","article-title":"Innate instruction of adaptive immunity revisited: The inflammasome","volume":"1","author":"Eisenbarth S. C.","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"155","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/0008-5472.CAN-09-3566","article-title":"Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity","volume":"70","author":"Aymeric L.","year":"2010","journal-title":"Cancer Res."},{"key":"156","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2009.12.004","article-title":"The inflammasomes: mechanisms of activation and function","volume":"22","author":"Latz E.","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"157","doi-asserted-by":"crossref","unstructured":"Weber, A., Wasiliew, P., Kracht, M.: Interleukin-1beta (IL-1beta) processing pathway. Sci. Signal <b>3<\/b>, cm1 (2010).","DOI":"10.1126\/scisignal.3105cm1"},{"key":"158","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2009-09-242784","article-title":"Graft-versus-host disease regulation by microbe-associated molecules and innate immune receptors","volume":"115","author":"Penack O.","year":"2009","journal-title":"Blood"},{"key":"159","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood-2009-08-237768","article-title":"Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation","volume":"115","author":"McDermott D. H.","year":"2010","journal-title":"Blood"},{"key":"160","first-page":"125","article-title":"Autologous spleen transplantation","volume":"134","author":"Szendr\u00f5i T.","year":"1993","journal-title":"Orvosi Hetilap (Budapest)"},{"key":"161","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0022-4804(84)90132-X","article-title":"The effect of tuftsin and splenectomy on mortality after intraabdominal sepsis","volume":"36","author":"Baker C. C.","year":"1984","journal-title":"J. Surg. Res."},{"key":"162","first-page":"127","volume":"30","author":"M\u00fccke D.","year":"1964","journal-title":"Tuftsin. Allerg. Immunol."},{"key":"163","first-page":"701","article-title":"Effects of tuftsin on postsplenectomy sepsis","volume":"97","author":"Chu D. Z.","year":"1985","journal-title":"Surgery"},{"key":"164","first-page":"27","article-title":"Tuftsin stimulates IL-1 production by human mononuclear cells, human spleen cells and mouse spleen cells in vitro","volume":"28","author":"Spirer Z.","year":"1989","journal-title":"J. Clin. Lab. Immunol."},{"key":"165","first-page":"61","article-title":"Infections after splenectomy","volume":"21","author":"Cormia F. E.","year":"1973","journal-title":"Clin. Res."},{"key":"166","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2008-10-185991","article-title":"A biomarker panel for acute graft-versus-host disease","volume":"113","author":"Peczesny S.","year":"2009","journal-title":"Blood"},{"key":"167","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/blood-2007-06-097287","article-title":"CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease","volume":"111","author":"Hori T.","year":"2008","journal-title":"Blood"},{"key":"168","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bbmt.2010.01.009","article-title":"Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute GVHD following matched unrelated donor BMT in children: A pediatric blood and marrow transplant consortium study","volume":"16","author":"Goyal R. K.","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"169","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1182\/blood-2009-06-225631","article-title":"Long-term recovery after hematopoietic cell transplantation: Predictors of quality of life concerns","volume":"115","author":"Wong F. L.","year":"2010","journal-title":"Blood"},{"key":"170","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1200\/JCO.1999.17.3.806","article-title":"Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: Graft-versus-host disease and transplant-related mortality","volume":"17","author":"Brown R. A.","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"171","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-Lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies","volume":"16","author":"Khouri I. F.","year":"1998","journal-title":"J. Clin. Oncol."},{"volume-title":"Hematology Basic Principles and Practice","year":"2005","author":"Bollard C. M.","key":"172"},{"key":"173","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM198903303201303","article-title":"Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms","volume":"320","author":"Sullivan M. D.","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"174","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bmt.1701064","article-title":"Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia","volume":"21","author":"Passweg J. R.","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"175","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12185-010-0509-9","article-title":"Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia","volume":"91","author":"Nishikawa S.","year":"2010","journal-title":"Int. J. Hematol."},{"key":"176","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","article-title":"Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation","volume":"28","author":"Martin P. J.","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"177","first-page":"135","article-title":"Development of tumors as a result of graft-versus-host reaction","volume":"1","author":"Cornelius E. A.","year":"1973","journal-title":"Exp. Hematol."},{"key":"178","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.bmt.1701772","article-title":"Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD)","volume":"23","author":"Gmeinhart B.","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"179","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1758-3284-1-29","article-title":"Oral carcinoma after hematopoietic stem cell transplantation: A new classification based on a literature review over 30 years","volume":"1","author":"Kruse A. L.","year":"2009","journal-title":"Head Neck Oncol."},{"key":"180","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/ajcp\/101.5.597","article-title":"A prospective study of cellular and immunologic changes in skin of allogeneic bone marrow recipients","volume":"10","author":"Norton J.","year":"1994","journal-title":"Am. J. Pathol."},{"key":"181","first-page":"9","article-title":"Inflammation and the origin of cancer","volume":"2","author":"Moss S. F.","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"182","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/canjclin.56.2.69","article-title":"Chronic inflammation: A common and important factor in the pathogenesis of neoplasia","volume":"56","author":"Schottenfeld D.","year":"2006","journal-title":"CA Cancer J. Clin."},{"key":"183","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1200\/JCO.2009.27.2146","article-title":"Immune regulation of cancer","volume":"28","author":"Disis M. L.","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"184","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1742-4690-6-116","article-title":"T-cell activation promotes tumorigenesis in inflammation-associated cancer","volume":"6","author":"Rauch D.","year":"2009","journal-title":"Retrovirology"},{"key":"185","doi-asserted-by":"crossref","unstructured":"van Besien, K.: Allogeneic stem cell transplantation in follicular lymphoma: Recent progress and controversy. Hematology Am. Soc. Hematol. Educ. Program, 2009, pp. 610\u2013618.","DOI":"10.1182\/asheducation-2009.1.610"},{"key":"186","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.4049\/jimmunol.179.3.1669","article-title":"IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease","volume":"179","author":"Ramirez-Montagut T.","year":"2007","journal-title":"J. Immunol."},{"key":"187","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.1999.17.7.2044","article-title":"Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral blood progenitor cell transplant: Evidence for a graft-versus-tumor effect","volume":"17","author":"Childs W.","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"188","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbmt.2006.09.011","article-title":"What\u2019s past is prologue: Lessons learned and the need for further development of allogeneic hematopoietic stem cell transplantation for renal cell carcinoma","volume":"13","author":"Ueno N. T.","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"189","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/CJI.0b013e318046f380","article-title":"Reduced intensity transplantation for metastatic renal cell cancer with 2-year follow-up","volume":"30","author":"Peres E.","year":"2007","journal-title":"J. Immunother."},{"key":"190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-4615-0451-1_13","article-title":"Allogeneic hematopoietic stem cell transplantation for cytokine refractory renal cell carcinoma","volume":"116","author":"Drachenberg D.","year":"2003","journal-title":"Cancer Treat. Res."},{"key":"191","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/ijc.25149","article-title":"Allogeneic hematopoietic stem cell transplantation in ovarian cancer - the EBMT experience","volume":"127","author":"Bay J. O.","year":"2010","journal-title":"Int. J. Cancer"},{"key":"192","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1172\/JCI34409C1","article-title":"Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells","volume":"118","author":"Takahashi Y.","year":"2008","journal-title":"J. Clin. Invest."},{"key":"193","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1128\/JVI.00274-10","article-title":"Evaluation of cellular determinants required for the in vitro XMRV entry of human prostate cancer and non-cancerous cells","volume":"84","author":"Bhosle S.","year":"2010","journal-title":"J. Virol."},{"key":"194","first-page":"223","article-title":"Host range and cellular tropism of the human exogenous gammaretrovirus XMRV","volume":"399","author":"Stiele K.","year":"2010","journal-title":"Virology"},{"key":"195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12185-008-0076-5","article-title":"Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells: Application for allogeneic transplantation","volume":"87","author":"Torikai H.","year":"2008","journal-title":"Int. J. Hematol."},{"key":"196","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood-2007-11-125492","article-title":"Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors","volume":"112","author":"Hambach L.","year":"2008","journal-title":"Blood"},{"key":"197","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbmt.2008.11.036","article-title":"Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy","volume":"15","author":"Aglietta M.","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"198","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2009.07886.x","article-title":"The allogeneic graft-versus cancer effect","volume":"147","author":"Ringd\u00e9n O.","year":"2009","journal-title":"Br. J. Haematol."},{"key":"199","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bbmt.2009.12.537","article-title":"Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: Hematologic malignancy outcomes are not impaired in advanced age","volume":"16","author":"Koreth J.","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"200","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/89907","article-title":"Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease","volume":"7","author":"Fontaine P.","year":"2001","journal-title":"Nat. Med."},{"key":"201","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1749-6632.1956.tb50883.x","article-title":"Conversion of solid neoplasms into ascites tumors","volume":"63","author":"Klein G.","year":"1956","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"202","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1073\/pnas.0337543100","article-title":"Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor \u03b2 loci sequence","volume":"100","author":"Mich\u00e1lek J.","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"203","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1158\/0008-5472.CAN-06-0591","article-title":"Single-cell cloning of human donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction","volume":"66","author":"Montagna D.","year":"2006","journal-title":"Cancer Res."},{"key":"204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MOT.0b013e32832ceef4","article-title":"Tolerance induction by removal of alloreactive T cells: In-vivo and pruning strategies","volume":"14","author":"Watson D.","year":"2009","journal-title":"Cur. Opin. Organ Transplant."},{"key":"205","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2008-06-165522","article-title":"AntiCD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI","volume":"113","author":"Li N.","year":"2009","journal-title":"Blood"},{"key":"206","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/blood-2009-08-235895","article-title":"Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for clinically applicable allodepletion strategy","volume":"115","author":"Samarasinghe S.","year":"2010","journal-title":"Blood"},{"key":"207","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.V114.22.655.655","article-title":"HLA-identical sibling-matched, CD34+ selected, T cell depleted peripheral blood stem cells following myeloablative conditioning for first or second remission acute myeloid leukemia (AML): Results of blood and marrow transplant clinical trial network BMT CTN protocol 0303","volume":"114","author":"Devine S. M.","year":"2009","journal-title":"Blood"},{"key":"208","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0396-317","article-title":"Fas ligand in human serum","volume":"2","author":"Tanaka M.","year":"1996","journal-title":"Nat. Med."},{"key":"209","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbmt.2007.10.002","article-title":"Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity","volume":"14","author":"Hartwig U. F.","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"210","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.tp.0000229435.58898.c5","article-title":"Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease","volume":"82","author":"Georgantas R. W.","year":"2006","journal-title":"Transplantation"},{"key":"211","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4049\/jimmunol.0800561","article-title":"Elective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand","volume":"183","author":"Bohana-Kastan O.","year":"2009","journal-title":"J. Immunol."},{"key":"212","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1182\/blood-2009-11-253559","article-title":"Bone marrow graft-versus-host disease: Early destruction of hematopoietic niche following MHC-mismatched hematopoietic stem cell transplantation","volume":"115","author":"Shono Y.","year":"2010","journal-title":"Blood"},{"key":"213","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1034\/j.1600-0609.2003.00078.x","article-title":"Serum levels of cytokines correlate to donor chimerism and acute graft-vs-host disease after hematopoietic stem cell transplantation","volume":"70","author":"Remberger M.","year":"2003","journal-title":"Eur. J. Haematol."},{"key":"214","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S1567-5769(03)00014-6","article-title":"Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy","volume":"3","author":"Talmadge J.","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"215","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0041-1345(00)02104-7","article-title":"Association between TGF-beta expression and severe GvHD in allogeneic bone marrow transplantation","volume":"33","author":"Leffel M. S.","year":"2001","journal-title":"Transplant Proc."},{"key":"216","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00007890-200101270-00022","article-title":"Transforming growth factor-beta inhibits lymphokine activated killer cytotoxicity of bone marrow cells: Implications for the graft-versus-leukemia effect in irradiation allogeneic bone marrow chimeras","volume":"71","author":"Billiau D.","year":"2001","journal-title":"Transplantation"},{"key":"217","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2133.2008.08555.x","article-title":"Transforming growth factor-beta-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease","volume":"158","author":"Su H.","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"218","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1158\/1078-0432.CCR-08-1656","article-title":"Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy","volume":"15","author":"Zhang Q.","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"219","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.cji.0000199193.29048.56","article-title":"Immune suppression in the tumor microenvironment","volume":"29","author":"Gajewski T. F.","year":"2006","journal-title":"J. Immunother."},{"key":"220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1389450033491181","article-title":"From TGF-beta to cancer therapy","volume":"4","author":"Huang X.","year":"2003","journal-title":"Curr. Drug Targets"},{"key":"221","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1582-4934.2008.00647.x","article-title":"TNF-alpha induces TGF-beta(1) expression in lung fibroblasts at the transcriptional level via AP-1 activation","volume":"13","author":"Sullivan D. E.","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"222","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signaling maintains leukaemia-initiating cells in chronic myeloid leukemia","volume":"463","author":"Naka K.","year":"2010","journal-title":"Nature"},{"key":"223","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3324\/haematol.11897","article-title":"CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation","volume":"93","author":"Atanackovic D.","year":"2008","journal-title":"Haematologica"},{"key":"224","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee S. J.","year":"2007","journal-title":"Blood"},{"key":"225","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2010.01.010","article-title":"A phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis","volume":"16","author":"Perkins J.","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"226","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/MPH.0b013e3181c6beef","article-title":"Graft-versus-leukemia effect on infant lymphoblastic leukemia relapsed after sibling hematopoietic stem cell transplantation","volume":"32","author":"Boatsman E. E.","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"227","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood-2005-08-3503","article-title":"Analysis of transgene-specific immune responses that limit in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation","volume":"107","author":"Berger C.","year":"2006","journal-title":"Blood"},{"key":"228","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbmt.2003.09.007","article-title":"Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution","volume":"9","author":"Gendelman M.","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"229","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/hum.2010.014","article-title":"Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Lupo-Stanghellini M. T.","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"230","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaut.2007.12.002","article-title":"Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation","volume":"30","author":"Rezvani A. R.","year":"2008","journal-title":"J. Autoimmun."},{"key":"231","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.4049\/jimmunol.0900159","article-title":"Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation","volume":"183","author":"Filatenkov A.","year":"2009","journal-title":"J. Immunol."},{"key":"232","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbmt.2006.01.001","article-title":"Peritransplantation vaccination with chaperon-rich cell lysate induces leukemia immunity","volume":"2","author":"Chen X.","year":"2006","journal-title":"Biol. Blood Marrow Transplant."},{"key":"233","first-page":"5825","article-title":"Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation","volume":"106","author":"Ho V. T.","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"234","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1517\/14712590903005552","article-title":"Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation","volume":"9","author":"Sangiolo D.","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"235","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2249.2009.03983.x","article-title":"Activating and inhibitor killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias","volume":"157","author":"Moretta A.","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"236","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.beha.2006.06.004","article-title":"Naturalkiller-cell-based treatment in hematopoietic stem-cell transplantation","volume":"19","author":"Passweg J. R.","year":"2006","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"237","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1182\/blood-2005-05-1897","article-title":"Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia","volume":"107","author":"Savani B. N.","year":"2006","journal-title":"Blood"},{"key":"238","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2005-02-0479","article-title":"The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions","volume":"106","author":"Sconocchia G.","year":"2005","journal-title":"Blood"},{"key":"239","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood-2008-05-158253","article-title":"Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib","volume":"113","author":"Yong A. S.","year":"2009","journal-title":"Blood"},{"key":"240","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1158\/0008-5472.CAN-04-2675","article-title":"BCR\/ABL promotes dendritic cell-mediated natural killer cell activation","volume":"65","author":"Terme M.","year":"2005","journal-title":"Cancer Res"},{"key":"241","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbmt.2008.02.015","article-title":"High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A\/ARF mutations retain susceptibility to alloreactive T cells","volume":"14","author":"Young F. M.","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"242","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood.V114.22.511.511","article-title":"Selecting haploidentical transplant donors for deploying optimal NK cell allotherapy","volume":"114","author":"Ruggeri L.","year":"2009","journal-title":"Blood"},{"key":"243","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller J. S.","year":"2005","journal-title":"Blood"},{"key":"244","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2009.24.4590","article-title":"NKAML: A pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia","volume":"28","author":"Rubnitz J. E.","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"245","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1200\/JCO.2009.26.4002","article-title":"Natural killer cell consolidation for acute myelogenous leukemia: A cell therapy ready for prime time?","volume":"28","author":"Verneris M. R.","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"246","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2009.12.008","article-title":"Expansion of NKG2A-LIR1-natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors\/HLA-ligand mismatched patients following hematopoietic cell transplantation","volume":"16","author":"Rathman S.","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"247","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.exphem.2010.02.006","article-title":"Natural killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression","volume":"38","author":"Decot V.","year":"2010","journal-title":"Exp. Hematol."},{"key":"248","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI7111","article-title":"IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation","volume":"104","author":"Teshima T.","year":"1999","journal-title":"J. Clin. Invest."},{"key":"249","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0609.2008.01108.x","article-title":"Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation","volume":"81","author":"Chen G.","year":"2008","journal-title":"Eur. J. Haematol."},{"key":"250","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation","volume":"14","author":"Bucher C.","year":"2009","journal-title":"Blood"},{"key":"251","first-page":"112","article-title":"Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunological aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning","volume":"54","author":"Petersen S. L.","year":"2007","journal-title":"Dan. Med. Bull."},{"key":"252","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1182\/blood-2009-11-255422","article-title":"Blockade of interleukin 23 signaling results in targeted protection of the colon and allows for separation of graft versus host and graft versus leukemia responses","volume":"115","author":"Das F. R.","year":"2010","journal-title":"Blood"},{"key":"253","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.4049\/jimmunol.181.11.7581","article-title":"A new approach to the blocking of alloreactive T cell-mediated graft-versus-host disease by in vivo administration of anti-CXCR3-neutralizing antibody","volume":"181","author":"He S.","year":"2008","journal-title":"J. Immunol."},{"key":"254","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/1097-0142(197003)25:3<663::AID-CNCR2820250323>3.0.CO;2-B","article-title":"Septicemia with Bacteroides in patients with malignant disease","volume":"25","author":"Sinkovics J. G.","year":"1970","journal-title":"Cancer"},{"key":"255","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/1097-0142(196909)24:3<631::AID-CNCR2820240331>3.0.CO;2-J","article-title":"Salmonellosis complicating malignant disease","volume":"24","author":"Sinkovics J. G.","year":"1969","journal-title":"Cancer"},{"volume-title":"The Immunobiology and Immunopharmacology of Endotoxins","year":"1986","author":"Sinkovics J. G.","key":"256"},{"volume-title":"Medical Oncology an Advanced Course","year":"1986","author":"Sinkovics J. G.","key":"257"},{"key":"258","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1182\/blood.V93.10.3267.410k22_3267_3275","article-title":"Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results of long-term follow-up of an open-label prospectively randomized trial","volume":"93","author":"Beelen D. W.","year":"1999","journal-title":"Blood"},{"key":"259","doi-asserted-by":"crossref","unstructured":"Sullivan, K. M., Dykewicz, C. A., Longworth, D. L., Boeckh, M., Baden, L. R., Rubin, L. R., Sepkowitz, K. A.: Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am. Soc. Hematol. Educ. Program, 392\u2013421 (2001).","DOI":"10.1182\/asheducation-2001.1.392"},{"key":"260","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbmt.2005.01.005","article-title":"Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation","volume":"11","author":"Blanc K.","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"261","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11427-009-0091-7","article-title":"Mesenchymal stem cells targeting the GVHD","volume":"52","author":"Wang L.","year":"2009","journal-title":"Sci. China C. Life. Sci."},{"key":"262","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/14653240802618085","article-title":"How do mesenchymal stromal cells exert their therapeutic benefit?","volume":"10","author":"Horwitz E. M.","year":"2008","journal-title":"Cytotherapy"},{"key":"263","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1158\/0008-5472.CAN-09-1865","article-title":"Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy","volume":"70","author":"Grisendi G.","year":"2010","journal-title":"Cancer Res."},{"key":"264","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/ijc.24946","article-title":"Direct and indirect contribution of bone marrow-derived cells to cancer","volume":"126","author":"Guest I.","year":"2010","journal-title":"Int. J. Cancer"},{"key":"265","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbmt.2010.01.011","article-title":"Co-transplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following non-myeloablative conditioning","volume":"16","author":"Baron F.","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"266","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/157488809789649269","article-title":"Mesenchymal stem cells for treatment and prevention of graft-versus host disease after allogeneic hematopoietic cell transplantation","volume":"4","author":"Toubai T.","year":"2009","journal-title":"Curr. Stem. Cell Res. Ther."},{"key":"267","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3324\/haematol.2009.015818","article-title":"Can antigen-specific regulatory T cells protect against graft vs. host disease and spare anti-malignancy alloresponse?","volume":"95","author":"Pidala J.","year":"2009","journal-title":"Haematologica"},{"key":"268","doi-asserted-by":"crossref","first-page":"e1000302","DOI":"10.1371\/journal.pbio.1000302","article-title":"Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1","volume":"8","author":"Amarnath S.","year":"2010","journal-title":"PLoS Biol"},{"key":"269","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.leukres.2009.11.024","article-title":"Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation","volume":"34","author":"Cao J.","year":"2009","journal-title":"Leuk. Res."},{"key":"270","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/096368970901805-619","article-title":"Superagonist CD28 antibody preferentially expanded Oxp3-expressing Treg cells and prevented graft-versus-host disease","volume":"18","author":"Kitazawa Y.","year":"2009","journal-title":"Cell Transplant"},{"key":"271","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1182\/blood.V114.22.4.4","article-title":"Adoptive immunotherapy with Tregs prevents GvHD and favours reconstitution after HLA haploidentical transplants for hematological malignancies","volume":"114","author":"Ianni M.","year":"2009","journal-title":"Blood"},{"key":"272","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI41072","article-title":"Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation","volume":"120","author":"Matsuoka K. I.","year":"2010","journal-title":"J. Clin. Invest."},{"key":"273","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbmt.2010.02.026","article-title":"Frequency of CD4+ CD25hiFOXP3+ regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host disease","volume":"16","author":"Mageneau J. M.","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"274","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/scd.2009.0216","article-title":"Role of CD4+CD25hiFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Vela-Ojeda J.","year":"2010","journal-title":"Stem Cell Dev."},{"key":"275","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1182\/blood-2008-06-165506","article-title":"Host natural killer cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease","volume":"113","author":"Pillai A. B.","year":"2009","journal-title":"Blood"},{"key":"276","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease","volume":"114","author":"Chen X.","year":"2009","journal-title":"Blood"},{"key":"277","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/cmi.2009.103","article-title":"CD40-activated B cells are more potent than immature dendritic cell to induce and expand CD4+ regulatory T cells","volume":"7","author":"Zheng J.","year":"2010","journal-title":"Cell Mol. Immunol."},{"key":"278","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1182\/blood-2007-05-092189","article-title":"Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to na\u00efve T cells, and favors expansion of regulatory T cells","volume":"110","author":"Balkow S.","year":"2007","journal-title":"Blood"},{"key":"279","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000406","article-title":"Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus","volume":"5","author":"Zelinskyy G.","year":"2009","journal-title":"PLoS Pathog"},{"key":"280","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1182\/blood-2009-03-208736","article-title":"The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response","volume":"114","author":"Zelinskyy G.","year":"2009","journal-title":"Blood"},{"key":"281","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/503874","article-title":"Reduced Foxp3 protein expression is associated with inflammatory disease during human lymphotropic virus type 1 infection","volume":"193","author":"Oh U.","year":"2009","journal-title":"J. Infect. Dis."},{"key":"282","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2008-02-140335","article-title":"Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease","volume":"112","author":"Saboury A. H.","year":"2008","journal-title":"Blood"},{"key":"283","first-page":"147","article-title":"Immunopathogenesis and treatment of the myelopathy associated to the HTLV-1 virus","volume":"48","author":"Carod-Artal F. J.","year":"2009","journal-title":"Rev. Neurol."},{"key":"284","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/bmt.2009.351","article-title":"HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome","volume":"45","author":"Chen Y.","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"285","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/bmt.2009.348","article-title":"Long-term disease-free survival after nonmyeloablative cyclophosphamide\/fludarabine conditioning and related\/unrelated allotransplantation for acute myeloid leukemia\/myelodysplasia","volume":"45","author":"Nelson R. P.","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"286","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.leukres.2009.11.020","article-title":"Unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients: a meta analysis","volume":"34","author":"Wang J.","year":"2009","journal-title":"Leuk. Res."},{"key":"287","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.moh.0000148762.05110.56","article-title":"Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: Separating graft-versus-leukemia effect from graft-versus-host disease","volume":"12","author":"Borroughs L.","year":"2005","journal-title":"Curr. Opin. Hematol."},{"key":"288","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1200\/JCO.2009.21.8073","article-title":"Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia","volume":"28","author":"Lim Z. Y.","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"289","first-page":"551","article-title":"Transplantation strategies for the management of patients with myelodysplastic syndromes","volume":"14","author":"Meletis J.","year":"2009","journal-title":"J. BUON (Balcan Union Oncology)"},{"key":"290","doi-asserted-by":"crossref","unstructured":"Wagner, J. E. (ed.): Umbilical cord transplantation. Semin. Hematol. <b>47<\/b>, 1\u2013103 (2010).","DOI":"10.1053\/j.seminhematol.2009.11.001"},{"key":"291","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2652-12-10","article-title":"Transplantation of selected or transgenic blood stem cells - a future treatment for HIV\/AIDS?","volume":"12","author":"H\u00fctter G.","year":"2009","journal-title":"J. Int. AIDS Soc."},{"key":"292","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/00002030-199813000-00005","article-title":"Neutralizing antibodies are positively associated wth CD4+ T-cell counts and T-cell function in long-term AIDS-free infection","volume":"122","author":"Carotenuto P.","year":"1998","journal-title":"AIDS"},{"key":"293","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/JVI.78.1.146-157.2004","article-title":"A single injection of recombinant measles virus vaccine expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV","volume":"78","author":"Lorin C.","year":"2004","journal-title":"J. Virol."},{"key":"294","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.0900350","article-title":"Tissue-specific abundance of regulatory T cells correlates with CD8+ T cell dysfunction and chronic retrovirus loades","volume":"183","author":"Myers L.","year":"2009","journal-title":"J. Immunol."},{"key":"295","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/infdis\/120.2.250","article-title":"An immunological explanation for the starry sky histological pattern of a malignant lymphoma","volume":"120","author":"Sinkovics J. G.","year":"1969","journal-title":"J. Inf. Dis."},{"key":"296","first-page":"61","article-title":"The first observation (in the late 1960s) of fused lymphoid cells continuously secreting a specific antibody","volume":"26","author":"Sinkovics J. G.","year":"2005","journal-title":"Bull. Molec. Med."},{"key":"297","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.TP.0000072014.83469.2D","article-title":"Donor lymphocyte infusion-mediated graft-versus-leukemia effect in mixed chimeras established with a nonmyeloablative conditioning regimen: Extinction of graft-versus-leukemia effects after conversion to full donor chimerism","volume":"76","author":"Mapara M. Y.","year":"2003","journal-title":"Transplantation"},{"key":"298","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.152.4.823","article-title":"Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes","volume":"152","author":"Fernandez-Cruz E.","year":"1980","journal-title":"J. Exp. Med."},{"key":"299","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","article-title":"High-dose cyclophosphamide as single agent, short-course prophylaxis of graft-versus-host disease","volume":"115","author":"Luznik L.","year":"2010","journal-title":"Blood"},{"key":"300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12026-009-8139-0","article-title":"High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation","volume":"47","author":"Luznik L.","year":"2010","journal-title":"Immunol. Res."},{"key":"301","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2009.03.509","article-title":"G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo","volume":"132","author":"Toh H. C.","year":"2009","journal-title":"Clin. Immunol."},{"key":"302","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/abbs\/gmp067","article-title":"A glucocorticoid amplifies IL-2-induced selective expansion of CD4+CD25+FOXP3+ regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation","volume":"41","author":"Xie Y.","year":"2009","journal-title":"Acta Biochim. Biophys. (Shanghai)"},{"key":"303","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbmt.2005.11.519","article-title":"Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusions are initiated by host-type antigen-presenting cells and regulatory T cells in early and long-term chimeras","volume":"12","author":"Xia G.","year":"2006","journal-title":"Biol. Blood Marrow Transplant."},{"key":"304","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbmt.2008.02.013","article-title":"The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells","volume":"14","author":"Symons H. J.","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6150-4-42","article-title":"Is evolution Darwinian or\/and Lamarckian?","volume":"4","author":"Koonin E. V.","year":"2009","journal-title":"Biol. Direct."},{"key":"306","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1161121","article-title":"APOBEC3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection","volume":"321","author":"Santiago M. L.","year":"2008","journal-title":"Science"},{"key":"307","doi-asserted-by":"crossref","DOI":"10.9783\/9781512815610","volume-title":"Experimental Studies in Equine Infectious Anemia","author":"Dreguss M. N.","year":"1954"},{"key":"308","doi-asserted-by":"crossref","first-page":"10774","DOI":"10.1073\/pnas.0402361101","article-title":"Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha","volume":"101","author":"Hatziioannou T.","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"309","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/sj.leu.2402598","article-title":"F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4","volume":"16","author":"Kone J.","year":"2002","journal-title":"Leukemia"},{"key":"310","first-page":"1651","article-title":"p53-Independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemia","volume":"7","author":"Howard J.","year":"1996","journal-title":"Cell Growth Differ"},{"key":"311","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/sj.onc.1204348","article-title":"Bcl-2 expression in F-MuLV-induced erythroleukemias: A role for the anti-apoptotic action of Bcl-2 during tumor progression","volume":"20","author":"Howard J. C.","year":"2001","journal-title":"Oncogene"},{"key":"312","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4049\/jimmunol.169.3.1626","article-title":"Role of passive apoptotic pathway in graft-versus-host disease","volume":"169","author":"Drobyski W. R.","year":"2002","journal-title":"J. Immunol."},{"key":"313","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4049\/jimmunol.174.3.1291","article-title":"The role of p53 and Fas in a model of acute murine graft-versus-host disease","volume":"174","author":"Yada S.","year":"2005","journal-title":"J. Immunol."},{"key":"314","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.2001.tb03713.x","article-title":"The role of human T cell lymphotropic virus type I tax in the development of cutaneous T cell lymphoma","volume":"941","author":"Zucker-Franklin D.","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"315","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbrc.2008.02.025","article-title":"Large number of the human microRNAs target lentiviruses, retroviruses, and endogenous retroviruses","volume":"369","author":"Hakim S. T.","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"316","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1073\/pnas.0913586107","article-title":"The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro","volume":"107","author":"Arbuckle J. H.","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"317","doi-asserted-by":"crossref","first-page":"e6778","DOI":"10.1371\/journal.pone.0005778","article-title":"Paleo-immunology: Evidence consistent with insertion of a primordial herpes virus-like element in the origin of acquired immunity","volume":"4","author":"Dreyfus D. H.","year":"2009","journal-title":"PLoS ONE"},{"key":"318","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1128\/JVI.01357-07","article-title":"Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses","volume":"82","author":"Rulli S. J.","year":"2008","journal-title":"J. Virol."},{"key":"319","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood-2007-11-126664","article-title":"A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML","volume":"113","author":"Breitenbuecher F.","year":"2009","journal-title":"Blood"},{"key":"320","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2009-03-209999","article-title":"Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome","volume":"114","author":"Kayser S.","year":"2009","journal-title":"Blood"},{"key":"321","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.leukres.2008.05.003","article-title":"The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia","volume":"32","author":"Kasper S.","year":"2008","journal-title":"Leuk. Res."},{"key":"322","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/leu.2009.212","article-title":"Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1\/Noxa axis","volume":"24","author":"Kojima K.","year":"2010","journal-title":"Leukemia"},{"key":"323","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1200\/JCO.2009.25.4888","article-title":"Phase I\/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia","volume":"28","author":"Ravandi F.","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"324","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/cmdc.200900394","article-title":"Novel imatinib derivatives with altered specificity between Bcr-Abl and FMS, KIT and PDGF receptors","volume":"5","author":"Skobridis K.","year":"2010","journal-title":"ChemMedChem"},{"key":"325","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.84.21.7408","article-title":"Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to trans-acting factor encoded by herpes simplex virus 1","volume":"84","author":"Mosca J. D.","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"326","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1128\/JVI.61.12.3726-3732.1987","article-title":"Activation of the human immunodeficiency virus by herpes simplex virus type 1","volume":"61","author":"Ostrove J. M.","year":"1987","journal-title":"J. Virol."},{"key":"327","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1099\/0022-1317-74-1-65","article-title":"Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harbored by a leptomeningeal cell line from a patient with multiple sclerosis","volume":"74","author":"Perron H.","year":"1993","journal-title":"J. Gen. Virol."},{"key":"328","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jmv.2194","article-title":"Human herpesvirus 6 variant a infects human term syncytiotrophoblasts in vitro and induces replication of human immunodeficiency virus type 1 in dually infected cells","volume":"67","author":"Csoma E.","year":"2002","journal-title":"J. Med. Virol."},{"key":"329","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1089\/aid.1995.11.1495","article-title":"Bidirectional enhancing activities between human T cell leukemia-lymphoma virus type I and human cytomegalovirus in human term syncytiotrophoblast cells cultured in vitro","volume":"11","author":"T\u00f3th F. D.","year":"1995","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"330","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/viro.1997.8449","article-title":"Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells","volume":"29","author":"T\u00f3th F. D.","year":"1997","journal-title":"Virology"},{"key":"331","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/039463200802100425","article-title":"Primary effusion lymphoma cells undergoing human herpesvirus type 8 productive infection produce C-type retrovirus particles","volume":"21","author":"Tinari A.","year":"2008","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"332","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa0904849","article-title":"Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2","volume":"362","author":"Celum C.","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"333","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1473-3099(08)70181-6","article-title":"Herpes simplex virus and HIV-1: Deciphering viral synergy","volume":"8","author":"Perre P.","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"334","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1086\/593214","article-title":"Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2\/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial","volume":"198","author":"Baeten J. M.","year":"2008","journal-title":"J. Infect. Dis."},{"key":"335","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1086\/650343","article-title":"A new class of dual-targeted antivirals: Monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2","volume":"201","author":"Vanpouille G.","year":"2010","journal-title":"J. Infect. Dis."},{"key":"336","first-page":"105","article-title":"Criminal collusion of herpes- and retro(lenti)viruses. Second International Conference of the M. Kaposi Research Foundation, Budapest, Hungary","volume":"4","author":"Sinkovics J. G.","year":"2000","journal-title":"Hungarian Venerological Archivum"},{"key":"337","first-page":"M2","article-title":"The immunovirology of Kaposi\u2019s sarcoma","volume":"III","author":"Sinkovics J. G.","year":"2006","journal-title":"The 22nd Annual Clinical Virology Symposium & Annual Meeting PanAmerican Society for Clinical Virology. Clearwater, FL. Abstracts, Session"},{"volume-title":"Graft-Vs-Host Disease","year":"2005","author":"Reddy P.","key":"338"},{"volume-title":"Clinical Oncology","year":"1995","author":"Stone R. M.","key":"339"},{"key":"340","doi-asserted-by":"crossref","unstructured":"Kolitz, J. E.: Acute myeloid leukemia and the myelodysplastic syndromes. In Chang, A. E., Ganz, P. A., Hayes, D. F., Kinsella, T. J., Pass, H. J., Schiller, H. J., Stone, J. H., Strecher, V. J. (eds): Oncology An Evidence-Based Approach. Springer Verlag, 2006, pp. 1155\u20131157.","DOI":"10.1007\/0-387-31056-8_63"},{"key":"341","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2010.28.6856","article-title":"Perspective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high risk acute myeloid leukemia. German-Austrian trial AMLHD98A","volume":"28","author":"Schlenk R. F.","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"342","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2009.813","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systematic review and meta-analysis of prospective clinical trials","volume":"301","author":"Koreth J.","year":"2009","journal-title":"JAMA"},{"key":"343","first-page":"361","article-title":"Chronic graft-versus-host disease after allogeneic stem cell transplantation: Challenges in prevention, science and supportive care","volume":"6","author":"Joseph R. W.","year":"2008","journal-title":"J. Support Oncol."},{"key":"344","doi-asserted-by":"crossref","unstructured":"Lim, J. H., Lee, M. H., Yi, H. G., Kim, J. H., Song, S. U.: Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: A report of two cases. Int. J. Hematol. Jun 1 (2010).","DOI":"10.1007\/s12185-010-0606-9"},{"key":"345","doi-asserted-by":"crossref","unstructured":"Prasad, V. K., Lucas, K. G., Kleiner, G. I., Talano, J. A., Jacobsohn, D., Broadwater, G., Monroy, R., Kurtzberg, J.: Efficacy and safety of ex-vivo cultured adult human mesenchymal stem cells (Prochymal TM) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate study. Biol. Blood Marrow Transplant. May 7 (2010).","DOI":"10.1016\/j.bbmt.2010.04.014"},{"key":"346","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0100-879X2010007500033","article-title":"Immunomodulatory effect of mesenchymal stem cells","volume":"43","author":"Herrero C.","year":"2010","journal-title":"Braz. J. Med. Biol. Res."},{"key":"347","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbmt.2009.07.006","article-title":"Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies","volume":"15","author":"Hamadani M.","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"348","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1158\/0008-5472.CAN-09-2860","article-title":"Interleukin-7 permits Th1\/Tc1 maturation and promotes ex vivo expansion of cord blood T cells: Acritical step toward adoptive immunotherapy after cord blood transplantation","volume":"70","author":"Davis C. C.","year":"2010","journal-title":"Cancer Res"}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/akademiai.com\/doi\/pdf\/10.1556\/amicr.57.2010.4.2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T02:52:08Z","timestamp":1740797528000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/amicr.57.2010.4.2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":348,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1556\/AMicr.57.2010.4.2"],"URL":"https:\/\/doi.org\/10.1556\/amicr.57.2010.4.2","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"type":"print","value":"1217-8950"},{"type":"electronic","value":"1588-2640"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}